40% Growth, but Margins Reveal the Squeeze

MIDHANI reported ₹239.5 Cr revenue in Q1 FY27, up 40.5% year-on-year and well ahead of the 15% growth guidance from FY26 calls. PAT grew 27% YoY to ₹16.5 Cr. Yet the quarter's profit quality hinges on a single fact: EBITDA margin collapsed to 19.4% from prior guidance of 24-25%—a miss of 500+ basis points. Operating leverage broke. This is not a miss to overlook; it reframes the growth story from earnings accretion into a volume-without-profitability quarter.

Management identified two material Q1 headwinds: an LPG crisis that nearly doubled furnace fuel costs (₹5 Cr impact), and adverse raw material price variance on nickel, molybdenum, tungsten, and cobalt (₹14 Cr drag). Together, these ₹19 Cr in input-cost pressures sat atop a ₹239.5 Cr revenue base—and crucially, fixed-price defense contracts prevented cost pass-through. A third, structural headwind compounds the problem: the company has transitioned from nomination-based (higher-margin) to competitive bidding (lower-margin) order capture. Management acknowledged this candidly: 'Now everything is competition only.' The shift from 25% to 20% margin territory reflects bidding intensity, not just cyclical commodity shocks.

The language—'we have hope' for Q3 normalization—signals confidence tempered by caution. Management expects margin recovery toward 20-21% once LPG and raw material volatility ease, but has not committed to a return to 24-25% guidance. The implication: even in a 'normalized' state, margins will run 3-4 percentage points below prior expectations.

A second concern emerges in sequential trends. Revenue fell 56.7% quarter-on-quarter; PAT fell 78.9% QoQ. Management attributes this to the lumpy, cyclical nature of defense order fulfillment and seasonal working capital movements. But the magnitude is sharp. For a company with a ₹2,329 Cr order book, a near-60% topline contraction in a single quarter raises questions about demand consistency and customer concentration. The order book is 66% defense (₹1,537 Cr subset), 21% space/ISRO, and 9% energy. That defense concentration, while aligned with India's indigenization strategy, means MIDHANI is highly sensitive to individual program milestones and capex cycles. The 78.9% PAT drop is material, even if seasonal.

The market initially rewarded the revenue beat. On day 1 post-announcement (Aug 12, 2026), MIDHANI popped +8.91% on strong delivery volume (33.1%). By day 5, the move had moderated to +4.82%—a fade of roughly 400 basis points. This suggests the market validated the topline but did not re-rate on margin confidence. At ₹423.95 (as of Aug 21), the stock trades ~7% below its all-time high of ₹456.6, well above its 52-week low of ₹266.65, and above all major moving averages (SMA20 ₹417.18, SMA50 ₹419.41, SMA200 ₹371.51). The technical picture is bullish, but momentum has flattened. FII ownership ticked up 124 basis points QoQ to 2.56%, a modest but positive signal; DII holdings fell 45 bps. No material insider selling near the highs; bulk trades in recent weeks were symmetric (MICROCURVES buy and sell at ₹445–446 per share), suggesting orderly index rebalancing rather than a directional signal.

The street's positioning—a pop that did not hold, FII nibbling but not rushing, no insider rot—suggests a 'wait and see' posture on the margin recovery narrative. The market has priced in the order book strength and long-term catalysts (AMCA, titanium ramp, global OEM certifications) but is skeptical of a rapid return to 24-25% EBITDA margins.

A critical piece of the bull case—a ₹1,000 Cr modernization capex over 3 years focused on downstream operations and efficiency improvements—remains in limbo. Management has submitted the proposal to the Ministry for approval. No timeline was provided. Until ministry sign-off arrives, FY27 capex remains maintenance-focused at ₹50-60 Cr. If approved, the capex is expected to deliver productivity and margin benefits 4–5 years post-completion. This long lag, combined with approval uncertainty, makes the capex a multi-year visibility item, not a near-term catalyst. It also means management's 15-20% full-year growth target (embedded in prior FY26 calls) is contingent on capex approval—a contingency that is not yet locked.